Tweet
The National Administration of Drugs, Foods and Medical Devices in Argentina admitted that COVID vaccines contain graphene oxide
The National Administration of Drugs, Foods and Medical Devices in Argentina- ANMAT (equivalent to the CDC) has admitted that COVID vaccines contain graphene oxide!!
The acknowledgment by Dr Patricia Aprea, Director of Evaluation and Control at ANMAT, came about as part of a court case that took place as a result of a vaccine death which is being prosecuted by prosecutor Carlos Insaurralde.
Translation
Argentine Republic - National Executive Power 2021 - Year of Tribute to the Nobel Prize in Medicine Dr. César Milstein
Report
Number: IF-2021-120912800-APN-DECBR#ANMAT
IPP No. 015787 "POZZI, Liliana" Graciela S/ investigation of causes of death"
Department. Functional Unit of Instruction No. 3 of the Judicial San Martin.
Dr. Patricia Ines Aprea
Chief
Directorate of Evaluation and Control of Biologics and Radiopharmaceuticals
National Drug, Food, and Technology Administration
Physician
IF-2021-120912800-APN-DECBR.pdf
The acknowledgment by Dr Patricia Aprea, Director of Evaluation and Control at ANMAT, came about as part of a court case that took place as a result of a vaccine death which is being prosecuted by prosecutor Carlos Insaurralde.
Translation
Argentine Republic - National Executive Power 2021 - Year of Tribute to the Nobel Prize in Medicine Dr. César Milstein
Report
Number: IF-2021-120912800-APN-DECBR#ANMAT
CIUDAD DE BUENOS AIRES
13 December 2021
Reference: INFORME AMPLIATORIO- EX-2021-45862892- -APN-DD#MS 13 December 2021
IPP No. 015787 "POZZI, Liliana" Graciela S/ investigation of causes of death"
Department. Functional Unit of Instruction No. 3 of the Judicial San Martin.
EXPANDED REPORT
a. The lot cited in the judicial office, CTMAV534 effectively corresponds to the COVID 19 Vaccine Vaccine AstraZeeca, which would have entered the Ministry of Health of the Nation through the System Covax (EX-2021-33243244- -APN-SAS#MS) in April 2021
b. This Directorate did not receive a request for analysis of samples from that batch for analytical tests.
c. Regarding the existence of residues in the vaccine, this was answered in June 2021 according to: "Regarding of the alleged finding of "residues" in the doses, this situation is inaccurate"
d. As for the composition of the vaccine in question, as declared, Graphene is within the components of it. It is suggested to accompany labels or authorised leaflets on the which can be noticed the components of the vaccine.
e. In relation to whether there are administrative complaints to that Ministry or the ANMAT about possible effects adverse of vaccines and if so what is the collateral damage reported, and also if they have knowledge of phenomena of body magnetism in post-vaccine inoculates; Bliss information should be collected in the competent area dependent on INAME.
b. This Directorate did not receive a request for analysis of samples from that batch for analytical tests.
c. Regarding the existence of residues in the vaccine, this was answered in June 2021 according to: "Regarding of the alleged finding of "residues" in the doses, this situation is inaccurate"
d. As for the composition of the vaccine in question, as declared, Graphene is within the components of it. It is suggested to accompany labels or authorised leaflets on the which can be noticed the components of the vaccine.
e. In relation to whether there are administrative complaints to that Ministry or the ANMAT about possible effects adverse of vaccines and if so what is the collateral damage reported, and also if they have knowledge of phenomena of body magnetism in post-vaccine inoculates; Bliss information should be collected in the competent area dependent on INAME.
Dr. Patricia Ines Aprea
Chief
Directorate of Evaluation and Control of Biologics and Radiopharmaceuticals
National Drug, Food, and Technology Administration
Physician
IF-2021-120912800-APN-DECBR.pdf